These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 12824187

  • 1. Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor.
    Buchanan FG, Wang D, Bargiacchi F, DuBois RN.
    J Biol Chem; 2003 Sep 12; 278(37):35451-7. PubMed ID: 12824187
    [Abstract] [Full Text] [Related]

  • 2. Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.
    Han C, Wu T.
    J Biol Chem; 2005 Jun 24; 280(25):24053-63. PubMed ID: 15855163
    [Abstract] [Full Text] [Related]

  • 3. Apc deficiency is associated with increased Egfr activity in the intestinal enterocytes and adenomas of C57BL/6J-Min/+ mice.
    Moran AE, Hunt DH, Javid SH, Redston M, Carothers AM, Bertagnolli MM.
    J Biol Chem; 2004 Oct 08; 279(41):43261-72. PubMed ID: 15294912
    [Abstract] [Full Text] [Related]

  • 4. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
    Ogunwobi O, Mutungi G, Beales IL.
    Endocrinology; 2006 Sep 08; 147(9):4505-16. PubMed ID: 16740977
    [Abstract] [Full Text] [Related]

  • 5. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C, Michalopoulos GK, Wu T.
    J Cell Physiol; 2006 Apr 08; 207(1):261-70. PubMed ID: 16331686
    [Abstract] [Full Text] [Related]

  • 6. Cyclooxygenase-2 inhibitor enhances whereas prostaglandin E2 inhibits the production of interferon-induced protein of 10 kDa in epidermoid carcinoma A431.
    Kanda N, Watanabe S.
    J Invest Dermatol; 2002 Nov 08; 119(5):1080-9. PubMed ID: 12445196
    [Abstract] [Full Text] [Related]

  • 7. TGF-β effects on prostate cancer cell migration and invasion are mediated by PGE2 through activation of PI3K/AKT/mTOR pathway.
    Vo BT, Morton D, Komaragiri S, Millena AC, Leath C, Khan SA.
    Endocrinology; 2013 May 08; 154(5):1768-79. PubMed ID: 23515290
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin E2 synergistically enhances receptor tyrosine kinase-dependent signaling system in colon cancer cells.
    Shao J, Evers BM, Sheng H.
    J Biol Chem; 2004 Apr 02; 279(14):14287-93. PubMed ID: 14742435
    [Abstract] [Full Text] [Related]

  • 9. Prostaglandins promote colon cancer cell invasion; signaling by cross-talk between two distinct growth factor receptors.
    Pai R, Nakamura T, Moon WS, Tarnawski AS.
    FASEB J; 2003 Sep 02; 17(12):1640-7. PubMed ID: 12958170
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells.
    Tveteraas IH, Müller KM, Aasrum M, Ødegård J, Dajani O, Guren T, Sandnes D, Christoffersen T.
    J Exp Clin Cancer Res; 2012 Sep 11; 31(1):72. PubMed ID: 22967907
    [Abstract] [Full Text] [Related]

  • 11. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME, Gagnon V, Mathieu I, Parent S, Asselin E.
    Int J Oncol; 2004 May 11; 24(5):1311-24. PubMed ID: 15067356
    [Abstract] [Full Text] [Related]

  • 12. PROSTAGLANDIN E2 stimulates cancer-related phenotypes in prostate cancer PC3 cells through cyclooxygenase-2.
    Madrigal-Martínez A, Constâncio V, Lucio-Cazaña FJ, Fernández-Martínez AB.
    J Cell Physiol; 2019 May 11; 234(5):7548-7559. PubMed ID: 30367494
    [Abstract] [Full Text] [Related]

  • 13. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
    Dajani OF, Meisdalen K, Guren TK, Aasrum M, Tveteraas IH, Lilleby P, Thoresen GH, Sandnes D, Christoffersen T.
    J Cell Physiol; 2008 Feb 11; 214(2):371-80. PubMed ID: 17654493
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner.
    Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M, Dubinett SM.
    Cancer Res; 2005 Jul 15; 65(14):6275-81. PubMed ID: 16024629
    [Abstract] [Full Text] [Related]

  • 15. Transactivation of EGFR/PI3K/Akt involved in ATP-induced inflammatory protein expression and cell motility.
    Lin CC, Lin WN, Cheng SE, Tung WH, Wang HH, Yang CM.
    J Cell Physiol; 2012 Apr 15; 227(4):1628-38. PubMed ID: 21678415
    [Abstract] [Full Text] [Related]

  • 16. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis.
    Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T.
    Hepatology; 2003 Sep 15; 38(3):756-68. PubMed ID: 12939602
    [Abstract] [Full Text] [Related]

  • 17. Agonist-specific transactivation of phosphoinositide 3-kinase signaling pathway mediated by the dopamine D2 receptor.
    Nair VD, Sealfon SC.
    J Biol Chem; 2003 Nov 21; 278(47):47053-61. PubMed ID: 12970364
    [Abstract] [Full Text] [Related]

  • 18. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
    Timoshenko AV, Xu G, Chakrabarti S, Lala PK, Chakraborty C.
    Exp Cell Res; 2003 Oct 01; 289(2):265-74. PubMed ID: 14499627
    [Abstract] [Full Text] [Related]

  • 19. Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.
    Ansari KM, Rundhaug JE, Fischer SM.
    Mol Cancer Res; 2008 Jun 01; 6(6):1003-16. PubMed ID: 18567804
    [Abstract] [Full Text] [Related]

  • 20. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells.
    Yang CM, Lin MI, Hsieh HL, Sun CC, Ma YH, Hsiao LD.
    J Cell Physiol; 2005 Jun 01; 203(3):538-46. PubMed ID: 15573401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.